arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Q32 Bio Inc.

QTTB

$8.87 ▼ -0.08 (-0.89%) at close

10 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Q32 Bio Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $109.1M

Dividend Yield —

Revenue Growth None

Op. Margin 31.5%

ROIC 31.8% ↗

FCF / Share $-2.73 ↗

Trailing P/E 3.7x

Price / Book 2.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$53.74M

— —

Net Income Profit after all expenses

$29.82M

↑ +162.5% —

Operating Margin Operating profit as % of sales

31.5%

↑ +111.1% 87th

FCF / Share Free cash flow per share

$-2.73

↑ +62.5% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	100.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	N/M	-90.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1232%)	1157.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14366%)	62.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+677%)	-68.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-959%)	—	—	—
EPS Growth YoY (%)	N/M	96.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-170966.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	94.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	11.2% Fair ↑ Fair Improving Year-over-year change in net income	-973.8% Weak ↓ Weak Declining Year-over-year change in net income	94.8% Excellent ↑ Excellent Improving Year-over-year change in net income	25.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.8% Weak ↑ Weak Improving Year-over-year change in net income	-87.0% Weak Weak Year-over-year change in net income	-85.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	62.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	86.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-2572.6% Weak Weak Year-over-year change in free cash flow	1.3% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	155.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	24.4% Excellent Excellent Compound annual revenue growth over 3 years	85.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	81.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	31.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+110%)	—	—	—	-282.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1983%)	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	59.7% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	55.5% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+362%)	—	—	-156.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1400%)	-281.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2449%)	—	—	—	—	—
FCF Margin (%) (%)	-62.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	280.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	-330.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	-1.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.42x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	22.97x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	-0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	31.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-920.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-56.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	59.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	27.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-71.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-102.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-21.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	71.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+373%)	—	29.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+96%)	-2.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-56.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-476%)	-65.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-538%)	-40.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	-28.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	76.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+407%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Interest Coverage (x)	—	—	-32.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-48.30M	$-77.97M	$-25.62M	$-33.99M	$-108.38M	$-217.43M	$-53.77M	$-38.22M	$-51.58M	$-11.39M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$4.37	$0.00	$-19.05	$0.06	$0.61	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.42	$-5.12	$-153.96	$-0.09	$-1.73	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.73	$-7.27	$-53.52	$-2.00	$-2.03	—	—	—	—	—
Book Value per Share (USD)	$3.27	$0.47	$-508.72	$3.10	$2.97	$3.90	$5.73	$5.26	$-14.96	—
Tangible Book Value per Share (USD)	$3.27	$0.47	$-508.72	$3.10	$2.97	$3.90	$5.73	$5.26	$-14.96	—
Basic Weighted Avg Shares (shares)	12.30M	9.32M	349,060	57.40M	55.28M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$43.70M	$65.41M	$14.61M	$158.44M	$174.68M	$196.91M	$254.20M	$199.17M	$122.74M	—
Total Equity (USD)	$42.01M	$5.67M	$-182.92M	$177.98M	$169.65M	$196.00M	$258.51M	$196.35M	$-39.45M	$-9.89M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$53.74M	$0.00	$-6.65M	$3.21M	$33.97M	$2.70M	$1.67M	$5.32M	—	—
Depreciation Expense (USD)	$391.00K	$487.00K	$499.00K	$1.29M	$8.35M	$7.96M	$6.32M	$1.29M	$684.00K	—
Net Income, GAAP (USD)	$29.82M	$-47.73M	$-53.74M	$-5.00M	$-95.76M	$-128.69M	$-103.92M	$-55.58M	$-29.99M	—
Operating Cash Flow (USD)	$-33.54M	$-67.72M	$-18.68M	$-113.66M	$-109.75M	$-94.33M	$-91.36M	$-42.56M	$6.48M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 39 quarters

Q32 Bio Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare QTTB with peers